(Q38238546)

31 August 2017

1 reference

title

Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective (English)

1 reference

31 August 2017

1 reference

1 reference

Pontiroli AE

1

1 reference

31 August 2017

Calderara A

series ordinal

2

1 reference

31 August 2017

Pozza G

series ordinal

3

1 reference

31 August 2017

publication date

1 November 1989

1 reference

Clinical Pharmacokinetics

31 August 2017

published in

1 reference

31 August 2017

volume

17

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

299-307

1 reference

The influence of drugs on nasal ciliary movement

31 August 2017

cites work

1 reference

12 December 2020

The effect of rectal and nasal administration of salmon calcitonin in normal subjects

1 reference

12 December 2020

Nasal absorption of propranolol in humans

1 reference

12 December 2020

Intranasal absorption of salmon calcitonin

1 reference

12 December 2020

Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects

1 reference

12 December 2020

Plasma immunoreactive atrial natriuretic peptide levels after subcutaneous alpha-hANP injection in normal humans

1 reference

12 December 2020

Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate

1 reference

12 December 2020

Bioavailability of nasally administered progesterone

1 reference

12 December 2020

Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.

1 reference

12 December 2020

Nasal Absorption of Natural Contraceptive Steroids in Rats—Progesterone Absorption

1 reference

12 December 2020

Effect of bile salts on nasal permeability in vitro

1 reference

12 December 2020

Intranasal glucagon raises blood glucose concentrations in healthy volunteers.

1 reference

12 December 2020

Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin.

1 reference

12 December 2020

Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene

1 reference

12 December 2020

Daily subcutaneous administration of human growth hormone in growth hormone deficient children

1 reference

12 December 2020

Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection

1 reference

12 December 2020

Nasal Absorption of Insulin in Dogs

1 reference

12 December 2020

Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.

1 reference

12 December 2020

Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration

1 reference

12 December 2020

Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

1 reference

12 December 2020

Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth

1 reference

12 December 2020

Clonidine accelerates growth in children with impaired growth hormone secretion

1 reference

12 December 2020

Intranasal drug delivery by spray and drops

1 reference

12 December 2020

Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men

1 reference

12 December 2020

Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents

1 reference

12 December 2020

The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature

1 reference

12 December 2020

Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects

1 reference

12 December 2020

Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects

1 reference

12 December 2020

Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds

1 reference

12 December 2020

Intranasal calcitonin and plasma calcium concentrations in normal subjects

1 reference

12 December 2020

Intranasal administration of alpha-human natriuretic peptide produces a prolonged diuresis in healthy man

1 reference

12 December 2020

Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter

1 reference

12 December 2020

The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.

1 reference

12 December 2020

Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin

1 reference

12 December 2020

Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans

1 reference

12 December 2020

Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.

1 reference

12 December 2020

The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: dose-response relationships

1 reference

12 December 2020

Nasal absorption of insulin: enhancement by hydrophobic bile salts

1 reference

12 December 2020

Alternative routes of peptide hormone administration

1 reference

12 December 2020

10.2165/00003088-198917050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1033709305

0 references

1 reference